ParcelBio

Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.

PMV mark · valuation
$41.2M
Oct 2026
Priced at
its seed round
Mar 2026
Total raised
$13.7M
Last round
Seed Round
May 2024
How much has ParcelBio raised?
$13.7Macross 1 recorded rounds · May 2024 – May 2024

Most recently, ParcelBio raised an undisclosed amount in its Seed Round (May 2024).

Free account
More of ParcelBio with a free account
  • ·The complete investor list: 13 names
  • ·Watch ParcelBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ParcelBio round by round

1 rounds
May 2024Seed Roundundisclosed▮
+ 1 more investors · free account

How much has ParcelBio raised?

ParcelBio has raised $13.7 million in total; 1 of its rounds is on record. The most recent was a seed round in May 2024.

ParcelBio investors

13 investors are on record for ParcelBio, including Y Combinator, Alumni Ventures, Pioneer Fund and Metaplanet Holdings. By type, the record holds 9 venture capital firms. The seed round in May 2024 drew 11 investors.

For fundraisers
Raising for a company like ParcelBio?

13 investors have backed ParcelBio — start your target list with the firms already writing checks in drug discovery.

See all 13 investors →

Frequently asked about ParcelBio

How much has ParcelBio raised?
ParcelBio has raised $13.7M in total across 1 recorded funding rounds.
When was ParcelBio's last funding round?
ParcelBio's most recent recorded round was Seed Round in May 2024.